MNTA - Momenta Pharmaceuticals EPS misses by $0.07 beats on revenue August, 10 2020 07:09 AM Momenta Pharmaceuticals Inc. Momenta Pharmaceuticals (NASDAQ:MNTA): Q2 GAAP EPS of -$0.48 misses by $0.07.More news on: Momenta Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...